US Stock MarketDetailed Quotes

SYRS Syros Pharmaceuticals

Watchlist
  • 1.6400
  • -0.0200-1.20%
Close Aug 30 16:00 ET
  • 1.6400
  • 0.00000.00%
Post 20:01 ET
43.97MMarket Cap-377P/E (TTM)

Syros Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Syros Pharmaceuticals Q2 2024 Earnings Date

Currency：USDJul 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
460.00K
0
-460.00K
Miss Est.
-83.76%
-100.00%
-100.00%
EPS
-0.77
-0.59
+0.18
Beat Est.
+40.93%
+54.62%
+23.17%
Analyst Rating
Strong Buy

Aug 13, 2024

Syros Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 360.000K--
--2024/Q3-- / 360.000K--
Jul 31, 20242024/Q20.000 / 460.000K--
May 14, 20242024/Q10.000 / 720.000K--
Mar 27, 20242023/Q4386.000K / 2.000M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 360.000K--
--2024/Q3-- / 360.000K--
Jul 31, 20242024/Q20.000 / 460.000K--
May 14, 20242024/Q10.000 / 720.000K--
Mar 27, 20242023/Q4386.000K / 2.000M--

Unlock Free Earnings Estimates

Syros Pharmaceuticals Earnings Reports

  • Syros Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Jul 31 07:00 ET

  • Syros Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 14 06:44 ET

  • Syros Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 27 06:54 ET

  • Syros Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 06:47 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 13, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg